Huanghe Pharmaceutical

Jiangsu Huanghe Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer based in Funing, Jiangsu Province, China, with a manufacturing history dating back to 1970. The company specializes in the development and large-scale production of generic medicines and traditional Chinese medicine (TCM) therapies across therapeutic areas such as cardiovascular health, metabolism, respiratory conditions, and allergies. Operating several GMP-certified facilities, the firm maintains an annual production capacity of billions of units for tablets and capsules and holds over 135 drug approval numbers. Huanghe Pharmaceutical was a key subsidiary of Fosun Pharma's Wanbang Biopharma division from 2014 until its divestment to an undisclosed entity in January 2022. The company is actively involved in the Chinese pharmaceutical industry's quality consistency evaluation process for generics, ensuring high standards for core products like Loratadine and Rosiglitazone.